|
Diltor Vladimir Araújo Opromolla (13 April 1934, São Paulo – 15 December 2004, Bauru) was a Brazilian physician and dermatologist internationally respected due to his lifetime work with leprosy patients and leprosy research. Dr. Opromolla performed all his work at Lauro de Souza Lima Institute in Bauru, São Paulo, a WHO reference hospital for dermatology. He taught dermatology and leprosy to countless doctors, nurses, and other health workers. Among other things, he was the first to introduce rifamycin in the treatment of leprosy, in 1963. Dr. Opromolla battled gastric cancer for the whole year of 2004 and died on December 15, 2004. ==References== * Fleury, RN. (Diltor Vladimir Araújo Opromolla ). ''Anais Brasileiros de Dermatologia'', 80(4), July/Aug. 2005. Biography and obituary. * (Tribute Paid to Doctor Diltor Vladimir Araújo Opromolla, Symbol of the Fight against Hansen's Disease ). Pan American Health Organization. * Naafs B, Silva E, Vilani-Moreno F, Marcos EC, Nogueira ME, Opromolla DV. Factors influencing the development of leprosy: an overview. ''Int J Lepr Other Mycobact Dis.'' 2001 Mar;69(1):26-33. Review. PMID 11480313 * Limalde S, Opromolla DV. First results on the treatment of leprosy with rifamycin. ''Chemotherapy''. 1963;10:668-78. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Diltor Opromolla」の詳細全文を読む スポンサード リンク
|